Bukwang Pharmaceutical Co., Ltd.
KRX:003000.KS
5,020 (KRW) • At close September 13, 2024
Overzicht | Financiële gegevens
Bedrijfsnaam | Bukwang Pharmaceutical Co., Ltd. |
Symbool | 003000.KS |
Munteenheid | KRW |
Prijs | 5,020 |
Beurswaarde | 343,642,594,000 |
Dividendpercentage | 0% |
52-weken bereik | 4,470 - 9,000 |
Industrie | Drug Manufacturers—Specialty & Generic |
Sector | Healthcare |
CEO | Sung-Gu Lee |
Website | https://www.bukwang.co.kr |
An error occurred while fetching data.
Over Bukwang Pharmaceutical Co., Ltd.
Bukwang Pharmaceutical Co., Ltd. operates as a pharmaceutical company in South Korea and internationally. It manufactures oral solid dosage forms, injections, oral solutions, external-use solutions, and ointments. The company offers products in various therapeutic areas, including liver disease treatments, such as Levovir and Legalon; diabetic complication products comprising Dexid and
Vergelijkbare Aandelen
Financiële Gegevens
Cijfers zijn in miljoenen (KRW)
Cijfers zijn in miljoenen (KRW)